Is Homoarginine a Protective Cardiovascular Risk Factor?

Area of Science:

• Biochemistry
• Physiology
• Metabolism

Background:

• Epidemiological studies suggest l-homoarginine is a novel cardiovascular risk factor.
• An inverse association exists between homoarginine levels and cardiovascular risk.
• Low homoarginine levels predict higher cardiovascular risk.

Purpose of the Study:

• To review the biochemistry, physiology, and metabolism of l-homoarginine.
• To summarize evidence linking homoarginine to cardiovascular disease.
• To identify research priorities for homoarginine's clinical utility.

Main Methods:

• Review of epidemiological studies.
• Analysis of homoarginine's biochemical and physiological roles.
• Synthesis of existing research on homoarginine and cardiovascular outcomes.

Main Results:

• l-homoarginine is an endogenous amino acid with potential cardiovascular protective effects.
• Low systemic homoarginine levels are associated with increased cardiovascular risk.
• Oral supplementation of homoarginine is a plausible therapeutic strategy.

Conclusions:

• Homoarginine is a promising candidate for cardiovascular risk assessment and treatment.
• Further research is needed to establish homoarginine's role as a prognostic factor and therapeutic target.
• Homoarginine supplementation may represent a novel approach in cardiovascular disease prevention.